Showing results (1-10 of 217) with videos related to
Sort By:
Pageof 22
Recenti Progressi in Medicina|December 20, 2021
[Target therapy and governance: the breast cancer PDTA of the Venetian Oncology Network.]Pierfranco ConteThe Oncologist|October 2, 2004
Safety of intravenous and oral bisphosphonates and compliance with dosing regimensPierFranco Conte, Valentina GuarneriThe Breast Journal|January 12, 2007
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspectivePierFranco Conte, Antonio FrassoldatiClinical Breast Cancer|May 22, 2012
The next generation of biologic agents: therapeutic role in relation to existing therapies in metastatic breast cancerPierFranco Conte, Valentina GuarneriThe Oncologist|July 18, 2009
Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapyValentina Guarneri, PierFranco ConteSeminars in Oncology|October 19, 2004
Bisphosphonates in the treatment of skeletal metastasesPierfranco Conte, Robert ColemanClinical Breast Cancer|February 14, 2008
Evolving nonendocrine therapeutic options for metastatic breast cancer: how adjuvant chemotherapy influences treatmentPierfranco Conte, Valentina Guarneri, Carmelo BengalaJournal of the National Cancer Institute. Monographs|November 2, 2011
Biomarkers predicting clinical benefit: fact or fiction?Valentina Guarneri, Elena Barbieri, Pierfranco ConteSeminars in Oncology|May 23, 2002
Pemetrexed: a promising new treatment for breast cancerJoyce A O'Shaughnessy, Alessandra Gennari, PierFranco ConteDrugs|July 12, 2013
Relapsed triple-negative breast cancer: challenges and treatment strategiesValentina Guarneri, Maria Vittoria Dieci, Pierfranco ContePageof 22